Patent №
US 10,955,422
Granted
2021-03-23
Filed 2016
Owner
BIOGEN MA INC.
Lab
—
AI components
1
evo
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
15120573
The invention relates to methods of assessing a patient's risk of developing Progressive Multifocal Leukoencephalopathy (PML).
Evolutionary computationG01N 33/6896C12Q 1/6883C12Q 2600/118C12Q 2600/158G01N 2333/025G01N 2800/28G01N 2800/50
AI classification
Evolutionary computation0.55
Planning0.00
Vision0.00
Natural language0.00
Machine learning0.00
Speech0.00
Knowledge representation0.00
AI hardware0.00
Ownership
BIOGEN MA INC.
assignment · 437260383
Assignors
PLAVINA, TATIANA, CARULLI, JOHN P., GORELIK, LEONID, COMPTON, TERESA
On an employer assignment, the assignors are typically the inventors.
From the same owner
METHODS FOR IMPROVED MEASUREMENTS OF BRAIN VOLUME AND CHANGES IN BRAIN VOLUMEUS 11,854,198 · 2023Methods For Improved Measurements Of Brain Volume and Changes In Brain VolumeUS 11,386,550 · 2022COMPOSITIONS AND METHODS FOR ASSESSING NEUROMUSCULAR FUNCTIONUS 11,040,119 · 2021APPARATUS AND RELATED METHOD TO FACILITATE TESTING VIA A COMPUTING DEVICEUS 10,420,497 · 2019COMPOUNDS AND METHODS FOR REDUCING TAU EXPRESSIONUS 10,407,680 · 2019METHOD OF ASSESSING RISK OF PMLUS 10,119,976 · 2018HETEROBICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGSUS 10,081,646 · 2018METHODS OF TREATING PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS COMPRISING SUBCUTANEOUSLY ADMINISTERING DACLIZUMABUS 9,809,652 · 2017